|
Sign In to gain access to subscriptions and/or personal tools.
|
TGF is Dispensable for Skin Tumorigenesis in Tg.AC Mice
Michael C. Humble
Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina 27514
Carl J. Szczesniak
Laboratory of Environmental Carcinogenesis and Mutagenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
Noreen C. Luetteke
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27514
Judson W. Spalding
Laboratory of Environmental Carcinogenesis and Mutagenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
Ronald E. Cannon
Laboratory of Environmental Carcinogenesis and Mutagenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
Laura A. Hansen
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892
David C. Lee
Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina 27514
Raymond W. Tennant
Laboratory of Environmental Carcinogenesis and Mutagenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
Alterations in growth factor signaling pathways frequently accompany the development and maintenance of epithelial neoplasia. Transforming growth factor a (TGF ) and its epidermal growth factor receptor have been thought to play an especially important role in epithelial neoplasia. In this study, mice were derived genetically deficient (null) in functional TGF expression and carrying the Tg.AC/v-Ha-ras transgene. The goals were to determine if (a) papillomagenesis was dependent on TGF and (b) progression to malignancy was dependent on TGF expression. Groups of male and female mice heterozygous or homozygous for the TGF null allele and hemizygous for the Tg.AC transgene were treated twice weekly for 10 or 15 wk with doses of 12-O-tetradecanoylphorbol-13-acetate (TPA) known to produce papillomas in Tg.AC mice. Papillomas were readily induced in both male and female TGF null mice. Malignant progression of papillomas was observed in all TGF null treatment groups. Additionally, we examined the response of TGF null mice to full thickness dorsal wounds, a stimulus known to promote papillomagenesis in Tg.AC mice. As in the TPA study, papillomas were induced in both male and female TGF null mice. These studies indicate that TGF is not required for the induction and maintenance of papillomas nor is it essential for the malignant conversion of papillomas in Tg.AC mice.
Key Words: Transgenic mice v-Ha-ras TPA wounding epidermal growth factor receptor (EGFR) oncogene
- 1. Chomczynski P (1993). A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques. 15: 532–537.[Web of Science][Medline]
[Order article via Infotrieve]
- 2. Chomczynski P and Sacchi N (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem.. 162: 156–159.[Web of Science][Medline]
[Order article via Infotrieve]
- 3. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ Jr, and Shipley GD (1992). Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res.. 52: 3224–3227.[Abstract/Free Full Text]
- 4. Cox DR (1972). Regression models and life-tables. J. R. Stat. Soc. B34: 187–220.
- 5. Derynck R (1986). Transforming growth factor-
: Structure and biological activities. J. Cell. Biochem.. 32: 293–304.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - 6. Derynck R (1988). Transforming growth factor
. Cell. 54: 593–595.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - 7. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, and Berger WH (1987). Synthesis of messenger RNAs for transforming growth factors
and β and the epidermal growth factor receptor by human tumors. Cancer Res.. 47: 707–712.[Abstract/Free Full Text] - 8. Derynck R, Roberts AB, Winkler ME, Chen EY, and Goeddel DV (1984). Human transforming growth factor-
: Precursor structure and expression in E. coli. Cell 38: 287–297.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - 9. DiGiovanni J (1992). Multistage carcinogenesis in mouse skin. Pharmacol. Ther.. 54: 63–128.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 10. Dlugosz AA, Cheng C, Williams EK, Darwiche N, Dempsey PJ, Mann B, Dunn AR, Coffey RJ Jr, and Yuspa SH (1995). Autocrine transforming growth factor
is dispensible for v-rasH3-induced epidermal neoplasia: Potential involvement of alternative epidermal growth factor receptor ligands. Cancer Res.. 55: 1883–1893.[Abstract/Free Full Text] - 11. Dlugosz AA, Hansen L, Cheng C, Alexander N, Denning MF, Threadgill DW, Magnuson T, Coffey RJ Jr, and Yuspa SH (1997). Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-rasH3 oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res.. 57: 3180–3188.[Abstract/Free Full Text]
- 12. Finzi E, Kilkenny A, Strickland JE, Balaschak M, Bringman T, Derynck R, Aaronson S, and Yuspa SH (1988). TGF
stimulates growth of skin papillomas by autocrine and paracrine mechanisms but does not cause neoplastic progression. Mol. Carcinog.. 1: 7–12.[Web of Science][Medline]
[Order article via Infotrieve] - 13. Furstenberger G, Rogers M, Schnapke R, Bauer G, Hofler P, and Marks F (1989). Stimulatory role of transforming growth factors in multistage skin carcinogenesis: Possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin. Int. J. Cancer. 43: 915–921.[Web of Science][Medline]
[Order article via Infotrieve]
- 14. Hansen LA and Tennant RW (1994). Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic Tg.AC mice. Mol. Carcinog.. 9: 143–156.[Web of Science][Medline]
[Order article via Infotrieve]
- 15. Higashiyama S, Abraham JA, Miller J, Fiddes JC, and Klagsburn M (1991). A heparin-binding growth factor secreted by macro-phage-like cells that is related to EGF. Science. 251: 936–939.[Abstract/Free Full Text]
- 16. Imamoto A, Beltran LM, and DiGiovanni J (1991). Evidence for autocrine/paracrine growth stimulation by transforming growth factor-
during the process of skin tumor promotion. Mol. Carcinog.. 4: 52–60.[Web of Science][Medline]
[Order article via Infotrieve] - 17. Jhappan C, Stahle C, Harkins RH, Fausto N, Smith GH, and Mer-lino GT (1990). TGF
overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell. 61: 1137–1146.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - 18. Jhappan C, Takayama H, Dickerson RB, and Merlino G (1994). Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. Cell. Growth Differ.. 5: 385–394.[Abstract]
- 19. Jonckheere AR (1954). A distribution-free k-sample test against ordered alternatives. Biometrika. 41: 133–145.[Free Full Text]
- 20. Kiguchi K, Beltran L, Dubowski A, and DiGiovanni J (1997). Analysis of the ability of 12-O-tetradecanoylphorbol-13-acetate to induce epidermal hyperplasia, transforming growth factor-
, and skin tumor promotion in wa-1 mice. J. Invest. Dermatol.. 108: 784–791.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - 21. Kiguchi K, Beltran L, You J, Rho O, and DiGiovanni J (1995). Elevation of transforming growth factor-
mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis. Mol. Carcinog.. 12: 225–235.[Web of Science][Medline]
[Order article via Infotrieve] - 22. Leder A, Kuo A, Cardiff RD, Sinn E, and Leder P (1990). v-Ha-ras transgene abrogates the initiation step in mouse skin tumori-genesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad Sci. USA. 87: 9178–9182.[Abstract/Free Full Text]
- 23. Luetteke NC, Qiu T H, Peiffer RL, Oliver P, Smithies O, and Lee DC (1993). TGF
deficiency results in hair follicle and eye abnormalities in targeted and Waved-1 mice. Cell. 73: 263–278.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - 24. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, and Dunn AR (1993). Mice with a null mutation of the TGF
gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell. 73: 249–261.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - 25. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, and Klagsbrun M (1993). Appearance of hep-arin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl. Acad. Sci. USA. 90: 3889–3893.[Abstract/Free Full Text]
- 26. Marquardt H, Hunkapiller MW, Hood LE, and Todaro GJ (1984). Rat transforming growth factor type 1 structure and relation to epidermal growth factor. Science. 223: 1079–1082.[Abstract/Free Full Text]
- 27. Massague' J (1983). Epidermal growth factor-like transforming growth factor. J. Biol. Chem.. 258: 13614–13620.[Abstract/Free Full Text]
- 28. Massague' J (1990). Transforming growth factor-
: A model for membrane-anchored growth factors. J. Biol. Chem.. 265: 21303–21396. - 29. Matsui Y, Halter SA, Holt JT, Hogan BLM, and Coffey RJ (1990). Development of mammary hyperplasia and neoplasia in MMTV-TGF
transgenic mice. Cell. 61: 1147–1155.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - 30. Rho O, Beltran LM, Gimenez-Conti IB, and DiGiovanni D (1994). Altered expression of the epidermal growth factor receptor and transforming growth factor-
during multistage skin carcinogenesis in SENCAR mice. Mol. Carcinog.. 11: 19–28.[Web of Science][Medline]
[Order article via Infotrieve] - 31. Salomon DS, Kim N, Saeki T, and Ciardiello F (1990). Transforming growth factor
: An oncodevelopmental growth factor. Cancer Cells. 2: 389–397.[Web of Science][Medline]
[Order article via Infotrieve] - 32. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, and Lee DC (1990). Overexpression of TGF
in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell. 61: 1121–1135.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - 33. Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, and Lee DC (1993). Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell. Biol.. 13: 320–330.[Abstract/Free Full Text]
- 34. Shing Y, Christofori G, Hanahan D, Ono Y, Sasada R, Igaradhi K, and Folkman J (1993). Betacellulin: A mitogen from pancreatic β cell tumors. Science. 259: 1604–1607.[Abstract/Free Full Text]
- 35. Shoyab M, Plowman GD, McDonald VL, Bradley JG, and Todaro GJ (1989). Structure and function of human amphiregulin: A member of the epidermal growth factor family. Science. 243: 1074–1076.[Abstract/Free Full Text]
- 36. Siegel S (1956). Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York, pp. 116–127.
- 37. Spalding JW, Momma J, Elwell MR, and Tennant RW (1993). Chemically induced skin carcinogenesis in a transgenic mouse line (Tg.AC) carrying a v-Ha-ras gene. Carcinogenesis. 14: 1335–1341.[Abstract/Free Full Text]
- 38. Tarone RE (1975). Tests for trend in life table analysis. Biometrika. 62: 679–682.[Abstract/Free Full Text]
- 39. Todaro GJ, De Larco JE, and Cohen S (1976). Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature. 264: 26–31.[CrossRef][Medline]
[Order article via Infotrieve]
- 40. Todaro GJ, Fryling C, and De Larco JE (1980). Transforming growth factors produced by certain tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA. 77: 5258–5262.[Abstract/Free Full Text]
- 41. Vassar R and Fuchs E (1991). Transgenic mice provide new insights into the role of TGF-
during epidermal development and differentiation. Genes Dev.. 5: 714–727.[Abstract/Free Full Text] - 42. Vaughn TJ, Paschall JC, and Brown KD (1992). Tissue distribution of mRNA for heparin-binding epidermal growth factor. Biochem. J.. 287: 681–684.[Web of Science][Medline]
[Order article via Infotrieve]
- 43. Watanabe T, Shintani A, Nakata M, Shing Y, Folkman J, Igarashi K, and Sasada R (1994). Recombinant human betacellulin. J. Biol. Chem.. 269: 9966–9973.[Abstract/Free Full Text]
- 44. Wong ST, Winchell LF, McCune BK, Earp HS, Teixido' J, Massague' J, Herman B, and Lee DC (1989). The TGF-
precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell. 56: 495–506.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 26, No. 4,
562-569 (1998)
DOI: 10.1177/019262339802600413

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. R. Schneider, S. Werner, R. Paus, and E. Wolf
Beyond Wavy Hairs: The Epidermal Growth Factor Receptor and Its Ligands in Skin Biology and Pathology
Am. J. Pathol.,
July 1, 2008;
173(1):
14 - 24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Thompson, B. A. Rosenzweig, Y. Tsong, and F. D. Sistare
Evaluation of in Vitro Reporter Gene Induction Assays for Use in a Rapid Prescreen for Compound Selection to Test Specificity in the Tg.AC Mouse Short-Term Carcinogenicity Assay
Toxicol. Sci.,
September 1, 2000;
57(1):
43 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Maronpot
The Potential of Genetically Altered Mice as Animal Models for Carcinogen Identification
Toxicol Pathol,
July 1, 1998;
26(4):
579 - 581.
[PDF]
|
 |
|
|
|